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Abstract

A NOVEL METHOD TO DETECT FUNCTIONAL SUBGRAPHS IN BIOMOLECULAR
NETWORKS

Sterling Wells Thomas, Doctor of Philosophy

A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor
of Philosophy at Virginia Commonwealth University
Virginia Commonwealth University, 2010
Danail Bonchev, Ph.D., Sc.D., Senior Fellow, Professor and Director of Research on
Bioinformatics, Center for the Study of Biological Complexity

Several biomolecular pathways governing the control of cellular processes have been
discovered over the last several years. Additionally, advances resulting from combining
these pathways into networks have produced new insights into the complex behaviors
observed in cell function assays. Unfortunately, identification of important sub-networks,
or “motifs”, in these networks has been slower in development. This study focused on
identifying important network motifs and their rate of occurrence in two different
biomolecular networks. The two networks evaluated for this study represented both
ends of the spectrum of interaction knowledge by comparing a well defined network
(apoptosis) with and poorly studied network that was early in development (autism).
This study identified several motifs that could be important in governing and controlling
cellular processes in healthy and diseased cells. Additionally, this study revealed an
inverse relationship when comparing the occurrence rate of these motifs in apoptosis
and autism.
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Chapter 1: Introduction
Over the past decade scientists have discovered many genetic/molecular
pathways responsible for the control of cellular processes. The purpose of this
control is to activate or deactivate processes responsible for specific functions in
the cell that are critical for cell survival, but not needed during the every step of
the cell cycle. These cellular functions under control include cell cycle
progression and division, DNA damage repair, apoptosis, synthesis and many
more. Additionally, the controlling pathways for these functions have a
significantly higher rate of mutation or deletion in solid malignant tumors.
Resulting from the discovery of signaling pathways and their high rate of
mutation and deletion, many new diagnostic and therapeutic studies are focused
on testing and repairing these signaling networks. One of the major challenges of
these studies is identifying all the networks formed by overlapping and redundant
signaling pathways commonly found in Homo sapiens. During my preliminary
studies it has been observed that biomolecular networks responsible for signaling
and control of apoptosis include several closely related proteins termed slave
that have similar functions but competitively suppress the activation of a
controlling protein (termed master). The slave/master proteins thus form a
redundant activation system that is resistant to minor mutations or deletions.
The hypothesis of this thesis is a master/slave arrangement in signaling
and regulatory networks represents a specific network motif that can be used to
identify other signaling and controlling networks as targets for diagnostics or
therapeutics.
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Figure 1 - Visual model of ideal master/slave relationship described in the hypothesis.

The following four stages of this study will aid in verifying motifs are
influenced by both evolutionary pressures and functional pressures and whether
this hypothesis holds true.
Stage 1: Construct a network of cellular gene/protein agents and potential
molecular regulatory pathways specific for apoptosis including the integrated
Bcl2 family of genes and proteins from interactions reported in BioGRID, Cancer
Cell Map, Human Protein Reference Database, IntAct, MINT, NCI/Nature
Pathway Interaction and Reactome databases. Network nodes and interactions
will be identified using mRNA expression data from gene arrays based on wholeblood samples from individuals diagnosed with adenocarcinoma of the lung
obtained from the Oncomine and Gene Expression Omnibus (GEO) databases.

Stage 2: Model and simulate Bcl2 family genes and protein networks to identify
subgraphs using cellular automata driven agent-based modeling. Calculate
topological measures of the discovered subgraphs to identify those that follow
the hypothesized master and slave node model. Topological measures include
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but are not limited to connectivity (Zagreb M2 and Betweenness), node degree,
number of second neighbor nodes (k1 and k2), number of first and second
neighbor edges (A(k)). Develop a mathematical model describing the
hypothesized relationship to be used in Stage 3 and 4.

Stage 3: Identify a differential network of cellular gene/protein agents and
potential gene regulatory pathways specific for functional changes associated
with the progression of adenocarcinoma of the lung. Network nodes and
interactions will be identified using mRNA expression data from gene arrays
based on whole-blood samples from individuals diagnosed with adenocarcinoma
of the lung obtained from the Oncomine and Gene Expression Omnibus (GEO)
databases. Identify networks subgraphs that follow the proposed hypothesis.

Stage 4: Identify a differential network of cellular gene/protein agents and
potential gene regulatory pathways specific for functional changes associated
with the progression of Autism Spectrum Disorder (ASD). Network nodes and
interactions will be identified using mRNA expression data from gene arrays
based on whole-blood samples from individuals diagnosed with ASD and
obtained from the Autism Genome Resource Exchange (AGRE). Topological
analysis will be limited to identification of subgraphs that follow the hypothesized
functional structure from Aim 1.

Significance:
Lung Adenocarcinoma is the most common Non Small Cell Lung Cancer NSCLC
and is the most common lung cancer among in life-long non-smokers. Lung
cancer occurs in 62.5 of every 100,000 men and women in the United States,
and is one of the most common occurring cancers (SEER).

Lung Cancer

commonly metastasizes and is found distally at diagnosis in 56% of patents.
Lung Cancer detected distally at diagnosis has a 5-year survival rate only of
3.5% (SEER). Adenocarcinoma accounts for 40% of the tumors at diagnosis and
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represents a significant challenge to the United States medical community. The
average age at diagnosis is 71 years, and although occurrence has recently
declined by 0.8%, is expected to increase with the aging “Baby-Boomer”
generation.
The

Genetic

Epidemiology

of

Lung

Cancer

Consortia

(http://epi.grants.cancer.gov/Consortia/) recently discovered potential familial
lung cancer gene (Bailey-Wilson, Amos et al. 2004). Although many lung tumors
are the result of environmental exposure (smoking), adenocarcinoma of the lung
most commonly occurs in non-smokers and suggests a familial link. The study
identified regions on chromosome 6 showing alterations in a significant number
of first degree family members with lung tumors, and less significant alterations
on chromosomes 12, 14, and 20. These are considered milestones in the
oncogenesis of lung cancer and do not represent a single hit cause of the
disease.
Recently, Drs. Bonchev and Kuznetsov (Kuznetsov, Thomas et al. 2008)
developed a unique method to identify early detection biomarkers in
Adenocarcinoma of the Lung. In this study Kuznetsov et al. identified a 5 gene
biomarker that could be used to classify lung cancer using mRNA expression.
The 5 gene marker set was revealed to represent cross-talk of 25 biomolecular
pathways in lung cancer. Based on the network analysis, these 25 pathways
have significant influence on the state of disease and control of cell growth and
apoptosis. This type of study is a good representation of amount of biomarker
research done in the lung cancer field. Based in the significant genetic and
proteomic research done on lung cancer, it represents a good model for this
study.
Autism Spectrum Disorders (ASD), which include Autism, Asperger’s Disorder,
and Pervasive Developmental Disorder-Not Otherwise Specified (PDD-NOS), are
severe, extensive neurodevelopmental diseases characterized by deficits in
social and emotional interactions and communication, as well as the presence of
stereotypic behavior and restricted interests. Recently, the Centers for Disease
Control along with Health Resources and Services Administration (HRSA)
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reported that one in 100 children is affected with an ASD, and declared the
condition “an urgent public health issue” [United States Centers for Disease
Control, 2009(2007)]. Clinicians are now faced with a large population of children
and teenagers with ASD who require accurate and comprehensive assessment
and effective treatments. Understanding the biological underpinnings, including
genetic characterization, of this group of disorders will directly impact diagnosis
and treatment development. In addition, costs associated with healthcare and
with special education of children with autism are enormous and have far ranging
consequences on society.
Twin and epidemiological studies have shown that ASD is the most frequently
inherited psychiatric disease. Understanding the biological factors that influence
the course and outcome of ASD is complicated by clinical heterogeneity in this
group of disorders, by multiple gene etiologies that predispose an individual to
the disease and by the innate complexity of dynamic gene/protein interactions.
Identification of cellular protein biomarkers and gene regulatory pathways
associated with ASD is essential to assess accurately the clinical prognosis and
allow for the earliest possible intervention to correct behavioral anomalies
associated with the disease. However, limited information of protein interaction
networks and complexes involved in ASD is available.
Insel and Abrahams both recently noted that understanding affected proteins and
their associated cellular pathways in ASD and other psychiatric disorders is a
necessary step that will improve diagnostic tests as well as treatments [(Insel and
Lehner 2007), (Abrahams and Geschwind 2008)]. Inroads relating to analysis of
genes involved in this complex phenotype have recently been reported.
Transcription profiling through the use of cDNA microarrays has permitted
simultaneous analysis of thousands of genes whose expression is either
increased or decreased in individuals with ASD [(Purcell, Jeon et al. 2001),
(Yonan, Palmer et al. 2003), (Baron, Liu et al. 2006), (Baron, Tepper et al. 2006),
(Hu, Frank et al. 2006), (Walker, Segal et al. 2006), (Nishimura, Martin et al.
2007), (Gregg, Lit et al. 2008)].

A bioinformatics analysis by Yonan et al.

(Yonan, Palmer et al. 2003) of autism positional candidate genes using biological
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databases identified 383 candidate genes predicted by a genomewide genetic
linkage analysis of families that had two or more members diagnosed with ASD.
In addition, peripheral blood and lymphoblastoid cell lines from autistic patients
have been used successfully to identify autism-associated gene changes in
peripheral cells ((Yonan, Palmer et al. 2003; Baron, Liu et al. 2006; Baron,
Tepper et al. 2006; Hu, Frank et al. 2006; Walker, Segal et al. 2006; Nishimura,
Martin et al. 2007).

Hu et al. (Hu, Frank et al. 2006) demonstrated that

lymphoblastoid cell lines from monozygotic twins discordant for severity of autism
have differential gene expression patterns as determined by microarray analysis.
Furthermore, genes with the greatest degree of differential expression were
those associated with nervous system development, structure and function.
Many of these same genes mapped to chromosomal regions determined in
earlier studies to be associated with autism candidate genes. A recent report by
Gregg et al. (Gregg, Lit et al. 2008) also characterized gene expression
differences in blood leukocytes of ASD patients using microarrays and found a
small group of genes expressed predominately in natural killer cells, among
others. Further, Nishimura et al. (Nishimura, Martin et al. 2007) utilized
lymphoblastoid cell lines from autism patients and identified 68 genes that were
dysregulated in common between autism with FMR1-FM and dup(15q). This
study (Nishimura, Martin et al. 2007) also demonstrated increased expression of
FMR1 interacting protein 1 (CYFIP1) in dup(15q) individuals, which suggests a
putative link between FMR1-FM and dup(15q).
Recently, Wall et al. (2009)(Wall, Esteban et al. 2009) compared gene networks
associated with autism to those of 432 additional neurological diseases with the
intent of defining shared molecular mechanisms and identifying new genes that
were important in autism. Sixty-six candidate autism genes were linked to one
other disorder—these were referred to as multi-disorder gene set (MDAG). Gene
networks and protein interactions with all MDAG genes were then defined, which
extended the potential autism-specific genes to 334 candidates. Of these 334
genes, 154 genes had not previously been linked to autism, but were
differentially expressed in autistic individuals. The authors concluded that at least
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a fraction of these genes may act as “sub-components” of the autism gene
network and will provide insights into current gaps of our knowledge of this
disease. Along this line, Purcell et al. (Purcell, Jeon et al. 2001) used microarrays
to study gene expression on post-mortem brain tissue from individuals with
autism and matched controls without any symptoms of autism. The study
demonstrated differential regulation of 30 genes in individuals with autism
compared to matched controls. Overall, these results affirmed that autism results
from the dysregulation of multiple genes, which is predicted to have a profound
effect on brain development.

Taken together, understanding the biological

underpinnings, including genetic characterization and functional pathways, of this
group of disorders will directly impact diagnosis and treatment development.
Innovation
This proposal is innovative because it proposes a new method to
determine functional groups in signaling and protein interaction networks. The
new method combines network topology analysis using existing methods and
equations with simulation for the purpose of classifying each node in the network
as master or slave. Existing network analysis tools provide an ideal way to
classify the nodes in a network as central or peripheral (eccentric). These
analyses make this classification based entirely on the structure of network,
assuming there are no edge weights.

This method is ideal for networks of

computers where each node shares basic characteristics. This method is also
ideal for early analysis of biological networks (signaling and protein interaction) to
determine what nodes are central assuming each node share based
characteristics. The shortcoming of this method is that in biological networks
each node does not always share basic characteristics. An example of this is
demonstrated by the diversity of protein structure and functionality found in most
protein interaction networks.

This proposal addresses this shortcoming by

combining the metrics described above with cellular automata simulation to
provide an additional classification of master and slave. The master/slave
relationship in the network topology might be considered by analogy with central
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and peripheral nodes, but provides an additional level of information where there
are multiple redundant pathways sharing the same or similar function.
Additionally, simulation combined with existing topology metrics being used to
describe the functionality of ASD progression networks has never been done and
is badly needed.
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Chapter 2: Network Construction

Summary:
This chapter is about construction of a network of cellular gene/protein
agents and potential molecular regulatory pathways specific for apoptosis
including the integrated Bcl2 family of genes and proteins from
interactions reported in BioGRID, Cancer Cell Map, Human Protein
Reference Database, IntAct, MINT, NCI/Nature Pathway Interaction and
Reactome databases. Searching and extracting interaction data from
databases represent the most common way of constructing biomolecular
networks. This chapter describes the individual methods and techniques
used to construct and maintain each of these databases.

The current standard for creating visual representations of interacting
molecules is to search curated databases of interacting molecules derived from
peer-reviewed publications. The process of populating these databases is called
“natural language searching”, a technology popularized with the rise of the
Internet.

Natural language searching includes two major processes: 1.

Identifying and extracting interaction data from peer-reviewed publications and 2.
Indexing based on an existing Molecular Interaction ontology of the Proteomics
Standards Initiative (PSI-MI) (Montecchi-Palazzi, Kerrien et al. 2009).

The

resulting record represents a binary interaction with supporting data (experiment
type and reference id). A third party technology (i.e. Cytoscape) can then search
these binary records and create n-ary interaction map describing linkages
between binary records that produce biological interaction/signaling pathways.
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Biomolecular Databases:
Biomolecular

interaction

databases

store

data

submitted

by

experimentalists and extracted from peer-reviewed publications. The data
extraction process is sometimes automated using optical character recognition
software with a list of key words that describe interactions. When not automated,
the extraction process is done manually. Subject matter experts (SME) read
publications that describe biomolecular interactions. When enough evidence is
described in the publications the SME will enter the interaction into the database
they are curating for. Over time updated versions of the databases are released
to the scientific community. Table 1 describes the data-capture technique and
update schedule for each of the databases used for this work.
Table 1 – Survey of publicly available sources of biomolecular interactions used in
network analsis.
Database Name

Data

Update

Collection

Schedule

References

Method
BioGrid

Manually

Monthly

thebiogrid.org

Populated and

(Stark,
Breitkreutz et al.)

Curated
ChEMBL

Automated

Ebi.ac.uk/chembl/

Periodic

(Overington

(unscheduled)

2009)

Periodic

(Sprinzak, Cokus

DIP

Manually

Dip-doe-mbi.ucla.edu

Populated and (unscheduled)

et al. 2009)

Curated
INTACT

Manually

Weekly

Ebi.ac.uk/intact/

Populated and

(Aranda,
Achuthan et al.)

Curated
IReflIndex

Manually

and Continuous

(Razick,

Irefindex.uio.no

Automated

Magklaras et al.

(Meta-DB)

2008)
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MatrixDB

Manually

Matrixdb.idcp.fr

Automated

and Six Months

(Chautard, Ballut
et al. 2009)

(Meta-DB)
MINT

Manually

Yearly

Mint.bio.uniroma2.id/mint/ Populated and

(Ceol,

Chatr

Aryamontri et al.)

Curated
MPIDB

Manually

Jcvi.org/mpidb/

Populated and

Yearly

(Goll, Rajagopala
et al. 2008)

Curated
Reactome

Manually

Reactome.org

Populated and

Continuous

(Croft, O'Kelly et
al.)

Curated

Construction of Networks
Using the newly released Cytocape version 2.7.0, an interaction database
search was conducted using the PSICQUIC Universal Web Service Client.
PSCICQUIC is a Google sponsored implementation of the PSI-MI that provides
programmatically accessible molecular interaction data through a standardized
web service. The database schema, XML and web service client was to be
installed locally at VCU to allow unpublished interaction data to be integrated into
the database that was to be created by mRNA data. This became unnessary and
will be described in a later section. PSICQUIC provides access to BioGrid,
ChEMBL, DIP, IntAct, IReflIndex, MatrixDB, MINT, MPIDB and Reactome
databases. To identify records important for this study the keyword apoptosis
was used.

As of writing this dissertation, a keyword search of PSCICQUIC

produced 15396 records. The search tool produced individual networks from
each of the data sources which were merged, and their overlap used as a basic
network. A cursory analysis of the search terms was done to evaluate the validity
of a semantic based analysis. Figure 2 describes the bases of this analysis
where terms representing key experimental methods represent overlaps that can
be used to improve the validity of a biomolecular network.

es”
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Figure 2 – Venn diagram of PSI-MI Tags from Apoptosis Network (PSI standard
introduced by HUPO)

IntAct is a database of interactions between bio-molecules ranging from
large protein complexes to small ligands and synthesized molecules. The search
included one term, Apoptosis, and produced a network of 6393 nodes and 14614
interactions (as defined by PSI Molecular Interaction standard) (Figure 3 The
nodes included 31 small molecules, 14 genbank sequences, 21 ensemble
entities, 3 genbank nucleolus entities, 90 genbank proteins, 70 unique IntAct
entities, 11 UniParc protein sequences, 6144 UniProt proteins. The network was
not completely connected, but included 169 components where the largest
connected network had 5724 nodes. The second largest network component had
43 nodes.
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Figure 3 - Largest apoptosis subnetwork from PSICQUIC search of apoptosis associated
biomolecules.
Search results from PSICQUIC connected databases (Figure 3) were
studied for biological validity by analyzing the PSI-MI tags using Starlight
Information Visualization System created by Pacific Northwest National
Laboratory (http://www.eurekalert.org/features/doe/2002-03/dnnl-ias061402.php).
PSI-MI tags describe the types of experiments that produced the interactions
described in the above databases. Table 3 shows PSI-MI tags from the
Apoptosis network. These terms are associated with different experimental
protocols that share common methods. Starlight extracted the common methods
from the PSI-MI tags and creates diagrams of overlap as seen in Figure 2. This
analysis identified records that use unproven protocols which can be excluded,
producing a higher confidence network.
Search results from Cytoscape were extracted in XML format (XGMML). This
format included all data provided with the interaction record (source,
experimental type, publication reference, etc. This XML was imported into
Starlight’s VIS system using the import wizard. Within the XML schema, edge
attributes and their associated values were exported and visualized. Starlight
identified 87,982 words, 219 of which were unique. Starlight was able to cluster
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these words into 17 groups that were visually filtered into 10 groups (Table 2)
that included words that described experimental techniques.
Table 2 – Occurrence of words describing the biological evidence of each interaction in
the apoptosis network.
Keyword/s

Occurrence in Edge Evidence

Physical, Association

9011

Bait, coimmunoprecipitation, anti

3387

Hybrid, approach, pooling

3123

Array,

assay,

microscopy, 2123

technology,

peptide,

chromatography, protein
Tag, coimmunoprecipitation, anti

1543

Pull

1534

Purification, tandem, affinity

1524

Interaction, direct

735

Reaction, phosphorylation

231

Chrystallography, x-ray, stelzl

159

Starlight has the ability to visually depict the clusters in three dimensions (Figure
4). The three dimensions were: occurrence, number of shared XML records, and
distance between records.
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Figure 4 - 3D clustering of key terms from PSICQUIC search using starlight visualization
tool.

Semantic modeling of data is becoming a more popular method of filtering
search results from web search tools (Nelson, Avraham et al.). Semantic
modeling is the bases for Starlight VIS, but represents only one type of analysis.
To verify the results a word map was generated of the same terms used in
Starlight.
In a word cloud the font size is determined by the occurrence of the word
in the source data (Kaser 2007). The algorithm for determining font size is:
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Figure 5 - Word cloud representation of interaction data from PSICQUIC search of
apoptosis. This search was compared with the Starlight search to identify which
experimental methods could be excluded to increase the quality of the apoptosis network.

Although the word cloud represents a different analysis of using semantic
grouping, the outcome is similar. From the analysis done in Starlight, combined
with the word cloud analysis, a more accurate network was prepared (Figure 6).
The number of protein coding genes is estimated to be around 23,000
(Stein 2004). This could yield 50,000 to 100,000 thousand proteins in human
cells. 6400 proteins would represent between 6 and 13% of the entire proteome.
It is possible that apoptosis includes a high percentage of the proteome, it is
more likely this network includes inaccuracies. To remove some of these
inaccuracies, the PSI-MI codes for the experiments for each interaction were
verified above.

76 Uniquely coded experiments were used to create the

17
Apoptosis network of 5714 nodes. 12 of the 76 were not associated with a
protocol or were associated with a poorly represented protocol. Removing the
records associated with these 12 missing protocols produced a network of 3414
nodes with 5890 edges (Figure 6).
Table 3 – PSI-MI returned during the PSICQUIC search for interactions associated with
apoptosis.
ID

Term (Type of experiment used to verify interaction)

MI:004

chromatography: affinity chromatography technologies

MI:006

anti bait coip: anti bait coimmunoprecipitation

MI:007

anti tag coip: anti tag coimmunoprecipitation

MI:0010 beta galactosidase: beta galactosidase complementation
MI:0012 bret: bioluminescence resonance energy transfer
MI:0013 Biophysical
MI:0016 cd: circular dichroism
MI:0017 fluorescence spectr: classical fluorescence spectroscopy
MI:0018 two hybrid
MI:0019 coip: coimmunoprecipitation
MI:0027 Cosedimentation
MI:0028 solution sedimentati: cosedimentation in solution
MI:0029 density sedimentatio: cosedimentation through density gradients
MI:0030 cross-link: cross-linking studies
MI:0031 protein crosslinking: protein cross-linking with a bifunctional reagent
MI:0040 electron microscopy
MI:0045 Experimental
MI:0047 far western blotting
MI:0049 filter binding
MI:0051 fluorescence: fluorescence technologies
MI:0053 fps: fluorescence polarization spectroscopy
MI:0054 facs: fluorescence-activated cell sorting
MI:0055 fret: fluorescent resonance energy transfer
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MI:0065 itc: isothermal titration calorimetry
MI:0067 light scattering
MI:0071 molecular sieving
MI:0077 nmr: nuclear magnetic resonance
MI:0081 peptide array
MI:0084 phage display
MI:0089 protein array
MI:0091 Not Found
MI:0096 pull down
MI:0099 spa: scintillation proximity assay
MI:0107 spr: surface plasmon resonance
MI:0111 dhfr reconstruction: dihydrofolate reductase reconstruction
MI:0112 ub reconstruction: ubiquitin reconstruction
MI:0114 x-ray: x-ray crystallography
MI:0115 yeast display
MI:0231 Not Found
MI:0276 Not Found
MI:0363 Not Found
MI:0364 Not Found
MI:0397 two hybrid array
MI:0398 two hybrid pooling: two hybrid pooling approach
MI:0399 2h fragment pooling: two hybrid fragment pooling approach
MI:0401 Biochemical
MI:0402 ch-ip:chromatin immunoprecipitation assays
MI:0404 comigration in gel: comigration in non denaturing gel electrophoresis
MI:0405 competition binding
MI:0406 deacetylase assay
MI:0411 elisa: enzyme-linked immunosorbent assay
MI:0412 emsa supershift: electrophoretic mobility supershift assay
MI:0413 emsa: electrophoretic mobility shift assay
MI:0415 enzymatic studies
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MI:0416 fluorescence imaging: fluorescence microscopy
MI:0417 Footprinting
MI:0419 gtpase assay
MI:0423 in-gel kinase assay: in-gel kinase assay
MI:0424 protein kinase assay
MI:0426 light microscopy
MI:0428 imaging techniques
MI:0423 one hybrid
MI:0434 phosphatase assay
MI:0435 protease assay
MI:0440 saturation binding
MI:0510 Htrf
MI:0515 methyltransferase as: methyltransferase assay
MI:0663 Not Found
MI:0676 Not Found
MI:0678 Not Found
MI:0728 Not Found
MI:0729 Not Found
MI:0826 Not Found
MI:0841 Not Found
MI:0921 Not Found
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Figure 6 – Visual representation of the optimized apoptosis network produced using
PSICQUIC enabled tools.

Analysis of Optimized Network
In order to predict the potential modules the largest network was analyzed
for centroid and degree. Centroid is calculated by focusing on two nodes (w,v)
and calculating the number of nodes that are closer to each of the nodes (w),
compared to the other node in the pair(v) (Scardoni, Petterlini et al. 2009). This
evaluation is then repeated exhaustively for an entire network. This produces a
centrality value where the higher the centroid index, the closer the node is to all
other nodes in the network. Degree is the total number of interactions of each
node.
To estimate the functional modules described in this document (Figure 1),
I calculated the centroid score and node degree for the largest connected
network of the Apoptosis network described above. Node degree provided a
general understanding of the connectedness of the entire network of 5724 nodes.
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Figure 7 shows the range of degrees or connections of the over 5724 nodes. The
range of degrees spans 378 to one, with one representing the most common
degree (A biomolecule with degree 378 is unrealistic and demonstrates the need
to improve the “biological validity” of the data).The protein with the highest
degree is Q9Y4K3 or E3 ubiquitin lygase, critical for Map Kinase activity. The
majority are terminal nodes with one connection that may connect to other
networks not included in the search, or final products. Only 20 of the 5724 nodes
had a degree of over 100, and without the centroid score most could not be
interpreted as central. In Figure 8 the centroid score is combined with node
degree to provide a clearer picture of centrality and control of the network.
Several of the proteins with high degrees have relatively low centroid values.
P25694 had a relatively high degree of 126, but a very low centroid score of 5281. This protein is responsible for scaffold deconstruction, a function that is not
involved in apoptosis activation.

P35438 also had a high degree and a low

centroid score. The protein is key to magnesium sensitivity and little to do with
initiating apoptosis. Both of these proteins represent the limitation of using node
degree to determine key proteins in functional specific networks.

Although

centroid provides a good measure of centrality, it cannot identify modules. The
average centroid score is -5444, but the end of the second largest quartile is 5480.

The heavy distribution of low scoring nodes demonstrated the low

sensitivity of the centroid score for functional modules, even when the module is
central to the network.
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Figure 7 - Log Distribution Histograms of Node Degrees from Apoptosis Network (Top is from the
complete network resulting from the search, bottom is the optimized network with unknowns and
low scoring biological evidence removed)
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Figure 8 - 3D Log Plot of Centroid Value by Node Degree by Occurrence number in Apoptosis
Network. (Top is from the complete network resulting from the search, bottom is the optimized
network with unknowns and low scoring biological evidence removed)

Functional modules of signaling networks with related outcomes have a
common structure of a “master” component that is highly connected and
activates a series of redundant effected components, which competitively inhibit
each other but lead to similar outcomes.

This property of the “master”

component, or “Regulating Promoter” in Figure 1, will be centrally placed within
the network. To determine whether existing centrality algorithms could predict
these modules I searched the IntAct database for all records associated with
Apoptosis and performed a centrality analysis using degree and centroid score.
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Chapter 3: Network Simulation of Bcl2 Family Proteins
Summary:
Bcl2 is a family of proteins responsible for apoptosis and cell cycle
pathways related to apoptosis. Bcl2 represents an ideal model of network
motifs that control large cellular functions. To identify motifs represented
in the Bcl2 family pathways I simulated Bcl2 family protein networks to
using cellular automata driven agent-based modeling. The outcome was
list of potential motifs that fit the behavior described in my hypothesis and
a deeper understanding of why this these motifs demonstrate very complex
behavior.

Cellular Automata analysis
Cellular Automata was introduced by John von Neumann and Stanislaw
Ulam in the 1960’s (Kier, Seybold et al. 2010). Von Neumann proposed twodimensional CA systems represented on a grid could change states following
rules derived from the state of the neighboring cells (Neumann and Burks 1966).
Von Neumann’s early CA systems allowed for up-to 29 different states and
provided limitless potential outcomes which made them become cumbersome to
work with. In the early 1980’s, Stephen Wolfram (Wolfram 1983) developed onedimensional CA systems where the state of a cell was determined from the state
of the cells during the previous iteration of the simulation. As iterations continued,
one-dimensional CA’s produced a finite number of outcomes. Rules based on
these outcomes have been used to develop a new theory for computational
analysis (Wolfram 2002).
Two-dimensional simulations have been adapted for simulations used in
molecular interaction and biology (Bonchev, Thomas et al. ; Kier 2008) . In these
simulations, the grid introduced by von Neumann represented interstitial space,
and each square was a molecule. The rules von Neumann used to change the
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state of his cells were modified to closely follow molecular mechanics.
Simulations resulting from these modified von Neumann systems were shown to
predict the boiling point and melting point of several compounds, and predict the
diffusion rate of one mixture through another (Kier, Seybold et al. 2010).
Following completion of the interaction searches and network topology
analysis, simulation using two dimensional CA systems was used to predict the
behavior of the interaction network(Strogatz 2001; Kier, Bonchev et al. 2005).
The rules were based on the maximal number of interactions for each molecule
represented in the network coupled with structural analysis of bonding regions
identified from 3D structures (from the protein databank). Structural analysis
included evaluation of multiple isoforms, and mutated versions of proteins for
lipophobicity and electrostatic potential using the Adaptive Poisson-Boltzmann
Solver with Amber force-fields as described by Baker et al. (Baker, Sept et al.
2001). These properties were mapped, color-coded and visualized for evaluation
using PyMOL. Areas with high lipophobicity and high electrostatic potential were
considered possible binding sights for the simulation but provided no additional
rule not already extracted from the literature searches.
Where graphical representations did not exist, generalizations were
employed based on biochemical characteristics of the predicted solvent
accessible surface combined with interaction reported in IntAct. Multiple
generalizations were based on most probable conformation providing a range of
bonding properties to be included in simulations were multiple confirmations were
possible. Simulations were done on a 64 bit multiple node supercomputing
cluster at the CSBC. CA models representing protein networks were comprised
of four-sided shapes (cells). The cells were variegated allowing up to 4 unique
protein-protein interactions per representative protein. Rules of motion were
based on probability and govern movement, joining and breaking of cells.
Movement, joining and breaking opportunities will be universal and have equal
probability. The only variations in behavior resulted from rules of interaction
defined above. Movement was applied randomly to each cell representing an
asynchronous model (as seen in natural processes). Types of bonds and
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complexes were tracked and represented the output of the simulation. Iterations
begin with a random distribution of cells and executed until a steady state was
identified (no change in binding for multiple iterations).
A new set of simulations was conducted where each rule will was
exhaustively changed and removed and run to reach a new steady state. As
described below, not all rules needed to be changed to obtain the complete
behavior of the network.. Many rules represented repetitive or redundant
functions and only needed to be simulated by a single rule change. Changes or
loss of steady state was tracked and evaluated for impact on the overall network.
The results were molecular bonding probabilities (strengths) that separate
equilibrium states or other simulation behaviors. Gene/protein representations
that lead to large changes in the simulations were considered potential regulatory
pathways with a “master” classification. Remaining genes/proteins were ranked
by predicted impact on simulation behavior with a “slave” classification.
Completion of these tasks resulted in network motifs that address the validity of
the hypothesis.

Bcl2 Simulations:
Two Bcl2 networks were simulated. The first includes four agents {Bcl2,
Bcl2L10 (BclX), Bax, Cytochrome C (CytC)}. These four agents may represent
multiple states (activation) and interaction. Four models were created that
included each of these agents. The variations between the models were based
on disagreements in the literature about the interaction of BclX with Bcl2. The
use of diverse but similar models also provided a useful method to identify
higher-level behaviors that were used to establish methods for analysis.
The first model if his network included no interaction between BclX and
Bcl2 (Figure 9). The model included changes in the states of Bax, Bcl2 and CytC.
Bax changed states from activated Bax to survival factor (SV), to represent
inhibition of Bax’s apoptosis promotion properties by BclX (Hoffmann and
Valencia 2004). Bcl2 changed states from activated Bcl2 to deactivated Bcl2.
This represents the inhibition of Bcl2’s apoptosis inhibition properties by Bax
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.CytC changed state from inactive to active CytC (AcytC), associated with the
release of cytochrome C from pores in the mitochondria promoted by Bax. CytC
also changed to SV to represent direct inhibition of the release of cytochrome C
from the mitochondrial pores by BclX and Bcl2 . This network represents five
separate pathways. The second model (Figure 10) includes each of the
interactions represented in Figure 9 but adds one change state. Bcl2 changed to
Bc2 homodimer (B2B2) to represent homodimeriation reported in the literature
(Figure 10)(Zhang, Szustakowski et al. 2009). The third model included each of
the interactions represented in the first model (Figure 9), but added two changed
states (Figure 11). Bcl2 changed to Bcl2 bonded to BclX (B2BX). BclX changed
to B2BX. Each of these interactions had been reported in the literature (Cheng,
Wei et al. 2001; Jourdan, Reme et al. 2009). The fourth model combined each of
the previous three to create a more complete interaction map (Figure 12). This
model includes eight individual pathways with seven changed states.
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Figure 9 – First model of the Bcl-2 network used in cellular automata simulation of proteins
associated with apoptosis.
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Figure 10 – Second model of the Bcl-2 network used in cellular automata simulation of proteins
associated with apoptosis. This model expanded on the second model by including the Bcl-2
homodimer reported in co-immunoprecipitation studies.
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Figure 11 – The third model: A different version of the second Bcl-2 model where the Bcl-2
homodimer was replaced with a Bcl-2, Bcl-X heterodimer.

Deactivation via Bax

Bcl-2

Competitive Binding

Bax

Deactivation via BclX

Bcl-2
Homodimer

Survival
Factor
(SV)

Competitive Binding

Bcl2/BclX
Complex
Competitive Binding
Inhibited via
Bcl2 &BclX

Competitive Binding

Bcl-X

Competitive Binding

CytC

Activated via Bax

ACytC

Figure 12 – The third Bcl-2 model used in cellular automata simulation. This model combined the
two versions of the second model where Bcl-2 can produce a homodimer, and a heterodimer with
Bcl-X
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When simulated using CA the results of the first model showed
convergence of the SV (representing survival) and AcytC (representing
apoptosis) concentrations between the bonding probabilities of 0.5 to 0.6 of BclX
interacting with Bax (inhibition of Bax). This result was used to identify other
convergence points in the other three models. New convergence points only
emerged in the third (Figure 11) and fourth (Figure 12) models. The new
convergence points in model three occurred from the interaction between BclX
and B2BX at probabilities 0.01 to 0.02 and 0.07 to 0.08. In the fourth model
convergence points emerged at the interactions of BclX and CytC at probabilities
of 0.72 to 0.7; the interaction between BclX and Bax at probabilities of 0.42 to
0.4; and the interaction between BclX and B2BX at probabilities of 0.015 to 0.01.
The resulting narrow ranges of existence of the survival state demonstrate the
significant challenges for drug discovery and clinical treatment of lung cancer.

The Bcl2 family-related apoptotic pathway is highly redundant of prosurvival and pro-apoptotic proteins, which provides a unique network for
modeling and simulation. The second Bcl2 network analyzed here was designed
to uncover the impact of this redundancy on the Bcl2 protein, which has limited
spatial accessibility. The model included the pro-survival proteins Bcl2 and BclX
(Bcl2L1) and the pro-apoptotic BID and BIM (Bcl2L11) (Xue, Chiu et al. 2003;
Kerrien, Alam-Faruque et al. 2007; Jourdan, Reme et al. 2009; Renouf, WoodBaker et al. 2009). We modeled the limited Bcl2 accessibility by altering the
dissociation constant from 1 to 0. Also included were non-Bcl2 proteins that were
reported to bind to Bcl2 family proteins in tumor formation. All interactions
included in the model had been reported in the IntAct database (Kerrien, AlamFaruque et al. 2007) to be related to cancer or apoptosis. The completed model
included 11 proteins with a total of 14 interactions (Figure 13). Two of the 11
proteins were isoforms of included proteins that were reported in different
pathways from the wild-type. To simulate the model each protein was
represented in a CA simulation by a single variegated cell. A variegated cell has
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more than one rule of behavior for each of its sides. The CA engine determines
whether a variegated cell can bind by evaluating the rule of the specific side of
the square cell that is neighboring another cell. In the case where a protein has
one binding side the variegated cell would have two rules, one binding and three
non-binding. The single binding side would be able to bind other proteins and the
three non-binding sides would not be able to bind with any other protein. The
ability to bind was determined by normalized probabilities (the sum of each cell’s
binding probabilities, describing interactions with other cells, cannot exceed one).
Of 14 interactions, four had published dissociation constants that were used as
breaking probabilities between two cells in the CA simulation. Where no
disassociation constant was reported, a breaking probability of zero was entered.
Each summation was run for approximately 10,000 iterations to reach a steady
state, and repeated 50 times.

Figure 13 – This expanded Bcl-2 network included interacting partners that were not known to be
Bcl-2 family members, but were similar in structure and had been reported as interacting partners
with known Bcl-2 family proteins.
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The CA input files included, among others, the list of all pairwise interactions and
their probabilities (Table 4).
Table 4 – List of interacting partners include in the expanded Bcl-2 network (Figure 13)

Bcl2

Bcl2

Bcl2

BclX:iso

Bcl2

NLRP1

Bcl2

BIM

Bcl2

PPP1CA

Bcl2

BIM:iso

Bcl2

BID

BclX

BID

BclX

NLRP1

BclX

PPP1CA

BclX

BIM

BclX

HRK

BclX:iso

SIVA1

PPP1CA

BAD

The model probabilities were normalized to a unit (Table 5).
Table 5 – List of probabilities created for each pathway found in the expanded Bcl-2 network (Figure
13)

BIM:iso-Bcl2 + Bcl2-Bcl2 + BID-Bcl2 + BclX:iso-Bcl2 + NLRP1-Bcl2 + BIMBcl2 + PPPICA-Bcl2

1

Bcl2-BclX:iso + SIVA1-Bclx:iso

1

BAD-PPP1CA + BclX-PPP1CA + Bcl2-PPP1CA

1

HRK-BclX + BID-BclX + NLRP1-BclX + BIM-BclX + PPP1CA-BclX
BID-Bcl2 + BID-BclX

1

BIM-Bcl2 + BIM-BclX

1

NLRP1-Bcl2 + NLRP1-BclX

1:

1
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Bcl2 had a dissociation constant of one, which was included in the control
simulation. Three other simulations were then run representing the absence of
the redundant BIM path (see Figure 13), the loss of Bcl2’s ability to dissociate
and the combination of the two. The terminal path including the BIM isoform was
monitored to evaluate the result of the changes. The loss of Bcl2’s ability to
dissociate from its binding partners and the loss of BIM resulted in a 20%
reduction of the BIM isoform complex. This is believed to be the result of
sequestered free Bcl2.
One may conclude that the highly redundant Bcl2 protein family network
provides an ideal model for studying the effects of damaged redundant network
paths in cancer, yielding alternative therapeutic approaches. The early results of
this simulation provided a link to the effects of a lost redundant path to the
sequestering of free Bcl2. We predict that the effects of a lost path, as a result of
carcinogenesis, could be overcome by altering the dissociation of Bcl2.

Resulting Motifs
In addition to the analysis of the importance of concentration in the Bcl2
family network previously described, two motifs were identified in the second
Bcl2 network (Figure 14). More network motifs would exist if the Bcl2 network
was analyzed in context of the larger apoptosis network, discussed in the next
chapter. The first identified network motif was a three-node two-edge directed
one (Figure 15), representing a basic signaling cascade. This motif occurred 40
times with a ratio of 1.05 (ratio = (observed in network)/(mean occurrence in
random networks)) with a p-value < 0.01.
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Figure 14 – 3-Node, 2 Edge Linear Motif

Figure 15 – 4-Node 4-Edge Biparallel Motif

The second motif of four nodes and four edges occurred twice with a ratio of 2
and p-value <0.01. Further analysis of these motifs and the three additional
networks that were dependent on the rest of the apoptosis network are discussed
in the next chapter.
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Chapter 4: Differential Analysis

Summary:
Recently, new methods to develop de novo networks from patient data
have been developed. To identify a differential network of cellular
gene/protein agents and potential gene regulatory pathways specific for
functional changes associated with apoptosis I compared these methods
to earlier described database searching methods. Although these methods
are useful in evaluating networks associated with well understood
functions in small populations, they can produce overly specific networks.
For this reason the motif analysis only included networks from the
databases described earlier.

Analysis of Microarray Data from Lung Cancer Patients
mRNA

microarray expression

data from individuals diagnosed

with

Adenocarcima of the lung were obtained from the Oncomine database, the NCBI
GEO database and EBI’s ArrayExpress database. Experiments that share
platforms, methods and patient characteristics including mRNA from adjacent
tissue were merged to provide a dataset of interaction data from at least 200
patients with adenocarcinoma of the lung.
The first steps of the Network Builder algorithm involves extracting random
directional vectors for each gene in Gene Ontology (GO) lists (Ashburner, Ball et
al. 2000; Bard 2003). As stated in the Introduction, correlation-based methods
show the most promise while maintaining the complex systems properties of
biological networks. Current tools that offer “de-novo” network creation only
calculate a pair-wise correlation. The tool used in this analysis correlated groups
of probes represented by vectors. Network Builder, the tool used in this study,
integrates a unique 2-D clustering with maximization of non-linear correlations
that maintains dynamic behavior when creating a de-novo network from
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experimental data. Recent studies by Zhang et al. (Zhang, Ji et al. 2007) have
described the strength of multi-gene correlation analysis compared to pair-wise.
This tool expanded on Zhang’s work by moving beyond three gene interactions.
This study utilized expression vectors representing 3 to 50 interactions, which are
evaluated using a combined clustering and correlation algorithm. The algorithm
aligned each vector individually on a two-dimensional grid. Clusters were
identified using GAP statistic. Each pair of two genes that presents more than
one significant cluster was recorded as having a potential interaction. The
algorithm then organized networks for the entire pool of 1000 genes. Subnetworks were created based on first neighbors for each gene starting with the
gene represented with the highest node degree (potential interactions). Random
vectors were extracted from each partition and non-linear correlation coefficients
(Rho) was calculated between groups of vectors from genes in a sub-network
between lung tumor samples and adjacent normal tissue. This value represented
a random base correlation. In contrast, partial regression uses a linear-based
reduction method that cannot account for compounding dynamic behaviors
commonly seen in networks.
New vectors were extracted from each partition after the data was
redistributed based on clinical features (i.e., stage of tumor, age, etc) that are
believed to vary in the patient pool. Spearman Rank Correlation Coefficient (Rho)
was derived for each sub-network with each directional clinical-based
distribution. Spearman correlation produces a coefficient between -1 and 1,
where as the distance from 0 (on a number line) increases, the statistical
dependence between two vectors increases. Clinical distributions with the largest
rho (exceeding random base correlation) derived from these groups of vectors
was selected and used in the following analysis representing directional base
correlation. Sub-networks were reduced gene by gene with new values for rho
calculated and comparisons done between patients with varying clinical
characteristics.
When rho for each group of directional vectors reached statistical significance
(using distance from 0 and within a small range), subnetworks were then
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combined to produce an accurate interaction network representing chromatin
associated pathways. Ontology terms were the used to partition the merged
network

into

a

subnetwork

of

apoptosis

pathways

associated

with

adenocarcioma of the lung and chromatin. This network will then be tested
against networks described earlier.

Each network will be studied to identify

topological limitations, i.e., the network diameter, node and edge degree as
reported (Milo, Shen-Orr et al. 2002; Dorogovtsev, Goltsev et al. 2003; Rives and
Galitski 2003).

These values described the maximum number of potential

interactions.
Subnetworks were then searched in the resulting network. It was expected
that subnetworks will match and rho values will be evaluated to see whether they
indicate a new unpublished interaction. Whenever the rho value was too small,
the interaction was labeled as a false positive and removed from the sub network
and a comparison was done. After this optimization step was complete, ontology
terms were added to each sub network to see if the sub network represents a
functional group. The chromatin example below provides an example of this denovo network building approach.

Figure 16 – Normalized expression values were plotted after being sorted (low to high) by different clinical
features. Each color represents a different clinical feature use for sorting the expression values.
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Chromatin (This work was done in collaboration with Dr. Vladimir Kunetsov
from the Bioinformatics Institute of Singapore):
An initial search of the Gene Ontology DB produced a list of 134 genes
associated with chromatin (Ashburner, Ball et al. 2000). This list included genes
that are associated with chromatin accumulation, assembly and remodeling.
Modeling and simulating the entire group of 134 genes, as described earlier, was
difficult. An alternative analysis of expression profiles using non-linear correlation
coefficients and a proprietary clustering algorithm was employed. Expression
data of 71 patients with adenocarcinoma of the lung compared were to 16
healthy samples (Rhodes, Kalyana-Sundaram et al. 2007). Expression data was
captured using an Affymetrix u95a platform. Results of the analysis identified
pack-years followed by TNM staging as providing the most predictable
coefficients (Figure 16). This analysis also identified 14 genes as potential core
genes (Figure 17 – Created by Dr. Danail Bonchev).
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Figure 17 – This network was produced using Ingenuity Systems IPA network analysis tool. A list of
proteins/genes was entered into the search tool and this network was produced. The list of
proteins/genes was produced using the correlation analysis described in the text.
Table 6 - Ontology of chromatin genes identified as potential biological markers using the analysis
described in the text. These markers could be used to discriminate between diseased and healthy
tissue.

H2AFV

Histone Construct

SFRS3

Splicing Factor/RNA Process

RB1

Transcription Regulator

HistH3

Histone Construct

CBX6

Transcription Regulator

HOXA9

Transcription Regulator
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Hist1H4C

Histone Construct

NXF1

Transporter

U2AF1

Unknown

SFRS1

Splicing Factor/RNA Process

SNRP70

Splicing Regulator/RNA

CASP11

Splicing Regulator/RNA

PRPF4B

Kinase

SFRS8

Splicing Factor/RNA Process

We then used additional mRNA expression data for individuals diagnosed
with adenocarcinoma of the lung from Oncomine (Rhodes, Kalyana-Sundaram et
al. 2007) and from Genome Expression Omnibus (GEO, 2007) (Barrett, Troup et
al. 2007). These were two very diverse datasets based on different platforms and
even patients of different ethnicity, selected as a test for the classification
reproducibility. The Oncomine U95A platform of expression data (12,600 probes)
involved a classification study of patients with lung malignancies (Bhattacharjee,
Richards et al. 2001) including 62 adenoncarcinomas and 17 normal samples.
The 62 adenocarcinomas were selected based on agreement between
assessments of two independent pathologists. Samples where one report did not
indicate pure adenocarcinoma were excluded, and the same was done with the
data for patients with secondary metastasis of a different morphology. This
produced a dataset of pure adenocarcinomas with no metastasis, tumor sizes of
1 to 8 cm, and all stages. The Bhattacharjee et al. expression data
(Bhattacharjee, Richards et al. 2001) were thus partitioned into five subsets, four
of which containing 15 or 16 tumor samples each randomly selected from the
pool of 62 samples, and one set of expression data with 17 normal samples. The
GEO U133A platform (22,284 probes) contained expression data from 27
adenocarcinoma patients with accompanying data from adjacent normal tissue
(Su, Chang et al. 2007). Expression data was thus presented in two sets of 27
samples each (normal and diseased ones).
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Our novel strategy limited strongly the starting gene list by focusing on
certain hypothesis as to which biological processes and molecular functions are
of importance in carcinogenesis. One can thus identify proteins that are strongly
affected in the different stages of lung adenocarcinoma. Recent studies on the
mechanisms of lung cancer pay a considerable attention on the chromatin
structure changes, and histone as the chief protein component of chromatin
(Cameron, Bachman et al. 1999; Reisman, Sciarrotta et al. 2003; Sasaki,
Moriyama et al. 2004; Gibbons 2005; Medina, Carretero et al. 2005). Proteins
related to DNA modification, MAP Kinases activity, and transcription were also
considered of importance. This choice enabled the compiling of two lists of
proteins. The first one with 98 genes was based on Gene Ontology Database
[GO] (Ashburner, Ball et al. 2000; Bard 2003) classifications provided by
Affymetrix Inc. The second list with 43 genes was a merge of Panther (Thomas,
Campbell et al. 2003) and David (Sherman, Huang da et al. 2007) ontology and
GO terms, of the four categories described above. Thus, our search started with
a combined list of 141 genes.
For each of the two gene expression datasets (Su et al. data (U133A)(Su,
Chang et al. 2007) GEO ID GSE7670; Bhattacharjee data (U95A)(Bhattacharjee,
Richards et al. 2001), provided by Oncomine (add reference) we first calculated
the Spearman non-parametric correlation coefficients ρ between pairs of
hybridization signals of all probesets of expressed genes presented on a
microarray for all patients included (complete cohort, normal and diseased).
Gene expression was defined as the normalized signal for each probeset ID
associated with a gene, as provided by Affymetrix Corporation. The number of
probeset IDs per gene ranged from one to eight. The results of the pair-wise
analyses did not provide clear results, due to large groups of predicted
interactions with the same correlation coefficients. In addition, the correlation
values were significant but not highly correlated. This result agrees with the
recent conclusions of Zhang et al. (Zhang, Ji et al. 2007) that pair-wise
correlation could be “a poor predictor of any molecular interaction associated with
signaling and control of cellular function”. Instead, Zhang used correlation
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between triples of genes. In this study, we applied a more sophisticated
correlation analysis which extends the correlation to larger groups of 3 to 100
genes and includes a clustering step (Thomas 2008). We employed twodimensional clustering using the so-called gap statistic to define a cluster of
probesets. No pre-filtering procedure was used for removing noise signals and
outlier patients. A cluster is defined as a group of expression signals where the
number of members is greater than one, and the expression values used for
input are from two different probesets representing two different genes (for
example, a cluster including expression signals for probeset A and probeset B
with a cohort of 20 samples would consist of 40 unpaired expression signals).
The Gap statistics uses the output of traditional clustering algorithms but
determines the difference between an internal dispersion of the variables within
the predicted cluster and a null distribution. The distance between two
nonnormalized expression signals was determined as Euclidean distance. The
two dimensional aspect of our clustering approach refers to the bivariate plot
graph in which the clustering is determined. The graph x coordinate stands for
the values for all expression signals for probeset of gene A across all samples,
while y is the same for a probeset of gene B across the same samples. So, if an
individual sample is denoted by k, the point on the graph representing that
sample is denoted as kxy and the number of such points equals the total number
of samples. Distance is then determined between each kxy and kx’y’ and
compared to the null distribution created by the Gap Statistics. If the sum of
distances within the entire subset is less than that in the null distribution, the
subset is reported as a cluster, as defined above. If the clustering of two
expression signals (probes A and B) produced two or more clusters, then an
interaction between the genes presented by the two expression signals from the
probes was recorded as a predicted interaction. Since this clustering step was
done exhaustively, each gene in the gene lists had several other genes identified
as potential interactions. The Spearman correlation coefficient ρ was then
determined for each list of potential interactions. All lists of each probeset
represented the hybridization signal of transcripts on microarray were then
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combined and the number of predicted interactions for each probesets was
counted. The count was used as a predicted node degree in a network
representation of highly correlating genes, the nodes and edges in which
represent the genes and their interactions, only correlation coefficients identified
as significant (p < 0.05) were used.
Supervised optimization was performed using Spearman’s ρ to compare potential
interaction lists resulting from clustering. Optimization was considered complete
when ρ reaches statistical significance (p < 0.001). The optimization process
included removing the probe with the lowest cluster number, and reevaluating
correlation. This was repeated for each probeset represented in the potential
interaction lists. When the correlation coefficient increased, the probeset was
permanently removed, and vice versa, when the correlation coefficient decreased
the probeset was returned to the potential interaction list. After completing the
optimization, network maps were built. Each probeset ID was replaced by a gene
symbol and when multiple probe IDs existed for a single gene correlation
coefficients were compared. If correlation coefficients were the same, the
duplicated probe ID was dropped. If the coefficients were not the same, a study
of the hybridization was done in the form of a literature search and the less
reliable probe ID was dropped. This last step was not necessary, due to the
normalization using Bioconductor (www.bioconductor.org) and similar tools done
prior to analysis (Zhang, Szustakowski et al. 2009). The count of genes in the
optimized list represents the final node degree in the network. The analysis of the
close neighborhood of this network makes possible the prediction of other
potential markers among the genes that are closely connected to the preliminary
selected candidate genes.

For all predicted interactions determined by the

correlation analysis we performed a literature search and Pathways Studio®
(Nikitin, Egorov et al. 2003) search for information on existing regulatory, binding
and other interactions or other relationships. This final step was used to verify
potential biological implications of the constructed networks. Each network was
also analyzed to identify topological limitations, such as network diameter, node
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and edge degree, centrality, etc. (Milo, Shen-Orr et al. 2002; Dorogovtsev,
Goltsev et al. 2003; Rives and Galitski 2003).

Resulting Motifs
As a result of the high level specificity of the chromatin analysis I
determined a that the network resulting from patient data was likely to not have
enough information to identify important controlling motifs. The network used
during the analysis was from the reduced, high confidence, PSICQUIC network
shown in Figure 6. To identify motifs I used the NetMatch Cytoscape Plugin
produced by the Bader lab at the University of Toronto (Ferro, Giugno et al.
2007). Five motifs were identified as possible candidates to address the
hypothesis.
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Figure 18 – 4-Node, 4-Edge
Non-Symmetrical Non-Linear
Motif

Figure 19 – 4-Node, 4-Edge
Symmetrical Non-Linear Bi-Fan
Motif

Figure 20 – 4-Node, 4-Edge Biparallel Motif

Figure 21 – 6-Node, 9-Edge Tri-parallel Motif

Figure 22 – 5-Node, 6-Edge Tri-parallel Motif

A selected subgraph is only important and is called “motif” if it occurs at a rate
different from that in random networks. To test this I generated 1000 random
networks with the same average node degree, diameter, number of nodes and
number of edges to compare the frequency of occurrence. Table 8 contains the
results of this analysis.
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Table 7 – Results of the motif search using NetMatch plugin with Cytoscape against the apoptosis
network. All the ratios are low when compared to the mean network counts from all 1000 random
networks.

Figure
Standard
Deviation
Mean from
Random Net.
Count in Network
Standard Error
z-stat
p-value
Ratio

18
4004.16

19
990.74

20
285.68

21
1369.7

22
33,890

38,217

8561

19,643

4689

36,935

3954
400
-85.57
<0.01%
0.103

5732
99
-28.55
<0.01%
0.669

706
9.03
-2096
<0.01%
0.036

2628
144.37
-14.27
<0.01%
0.560

39084
3572.4
0.587
27.8%
N/A

FANMOD (Wernicke and Rasche 2006) is another tool commonly used for
the identification and analysis of motifs in networks. FANMOD has strict
formatting requirements that limit ability of this tool to read biomolecular networks
generated from database searches (described earlier). The FANMOD input file
must include only integers, representing vertices, and have one edge per row.
Additionally the software can only read windows encoded Unicode 8-bit text files,
even when the program is installed on a Linux or Unix machine. Due to these
limitations, I was only able to analyze the autism network described in Chapter 5.
The methods used to convert the network to be analyzed in FANMOD and the
results are described in that chapter.
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Chapter 5: Autism Networks

Summary:
To identify whether the motifs found in apoptosis were limited to
only networks that are well studies I created a network of interactions
reported in Autism Spectrum Disorder (ASD). From this network we
identified the same motifs as those found in apoptosis, including increased
significance in the larger motif. Interestingly, in the apoptosis network we
found motif counts significantly lower than those in random networks,
while in Autism we found motifs in consistently higher abundance than
found in random networks.

Analysis of Protein Interaction Networks
To generate a protein interaction network associated with apoptosis, I
used the PSICQUIC search tools built into Cytoscape. This tool was unable to
identify any interactions associated with Autism. The PSICQUIC tool is designed
to use an XML based standard that has a limited ontology. As a result the user
can get a network from a meta-database search with better specificity than
searching each database individually. This removes the redundancy and reduces
the false hits. Unfortunately, this also removes the diversity of terms available.
Since most interactions are associated with cancer, without a cancer related
term, it is difficult to get a larger representative network from PSICQUIC.
NCBI provides an additional search tool built into Cytoscape (Sayers,
Barrett et al.). This tool allows Cytoscape users to search with the Entrez utility
across NCBI’s databases. By using this tool, I was able to generate a network of
biomolecular interactions in Autism with 1621 nodes and 3997 edges (Figure 23).
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Figure 23 - Autism network produced using the NCBI search tool. This was the only search target
and tool that was able to produce a network using search terms associated with autism.

In addition to NetMatch, FANMOD was used to search for and analyze
motifs in this Autism network. NCBI uses integers as identifiers in networks
generated by the Entrez tool. FANMOD is sensitive to gaps (missing integers) in
the set of integers representing nodes, and cannot accept integers larger than
65,500. The Autism network has 1621 nodes with, integers ranging from 100 to
37,547,124. To compress the range of integers, I factored the numbers on a log
scale ranging from 4 to 4000. The result was a set of integers that fit into the
range of FANMOD. The factoring included a rounding step were factoring did not
produce an integer. This step did result in the loss of several nodes, which may
have significant impact on the results. This was made clear by the statistics of
the Apoptosis network reported by FANMOD (number of nodes = 65107, number
of edges = 1888). The error in node count is a programming bug where
FANMOD reports the highest integer as the node count for the network. The loss
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of half the edges could be a combination of multiple records (edges) for the same
interaction, and loss resulting from the factoring and rounding of the integers.

Resulting Motifs
As described in the previous chapter, 1000 randomized autism networks
were generated to determine how far the occurrence count of the motifs deviated
from that of random networks using the NetMatch Cytoscape plugin. The autism
network included all five motifs (figures 18 - 22) which deviated significantly from
the average 1000 random networks (Table 9).
Table 8 - Results of the motif search using NetMatch plugin with Cytoscape against the autism
network. All the ratios are high when compared to the mean network counts from all 1000 random
networks.

Figure
Standard
Deviation
Mean from
Random Net.
Count in Network
Standard Error
z-stat
p-value
Ratio

18
10,402

19
696.56

20
31.87

21
465.5

22
399.04

15,510

4760

50.24

561

482.5

25158
1040
9.27
<0.01%
1.62

9836
73.42
69.12
<0.01%
2.07

272
1.01
220
<0.01
5.41

2412
46.6
39.75
<0.01
4.30

2412
39.9
48.35
<0.01
5.00

The results obtained from FANMOD (Table 9) did not include the same
motifs found using the NetMatch plug-in (Table 8), although, the motifs that were
found existed in the same high ratios as discovered using NetMatch.
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Table 9 - Results of the motif search using FANMOD against the autism network. All the ratios are
high when compared to the mean network counts from all 1000 random networks.

Motif

Standard

6.38 e-6

2.67 e-6

2.36 e-4

4.43 e-5

z-score

5.39

4.4594

4.06

3.54

p-value

0.005

0.004

0.005

> 0.01

Ratio

9.43

4.67

4.61

2.4

Deviation

Of the two tools used to study motifs, NetMatch is likely more reliable
because it uses the networks in the original formatting without any modification.
FANMOD is a more robust tool, because it has the ability to exhaustively search
for motifs of a defined size. Unfortunately, the limited input formats make it less
reliable for biomolecular networks created using interaction databases, even
when the resulting network uses integers as identifiers for nodes. Accounting for
the qualities and limitations of each program, high ratios were exhibited in all
motifs found in the Autism network. Since it was found using both programs, it is
difficult to define it as an artifact, but it is more likely a descriptive characteristic of
the known Autism network, and could be useful in understanding the depth of
existing knowledge about signaling and regulation associated with Autism. Due
to the uncertainty associated with the FANMOD results, the following chapter will
only discuss the NetMatch results. Further analysis with FANMOD should be
performed for additional validation, but only in combination with a more robust
input file conversion tool.
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Chapter 6: Discussion and Future Work

Summary:
The data resulting from this study has provided some support for the
hypothesis that a master slave arrangement shown in a motif represents a
key functional group of the network. The results between apoptosis and
autism were inconsistent, but within each disease type they were very
consistent. This suggests the ratio of occurrence is sensitive to the
network completeness and could be exploited as a measure for this
completeness, in addition to providing an indication of the presence of
functional groups, affected by disease.

Discussion
The purpose of these studies was to discover if there is an optimized subnetwork (motif) structure that could be used to identify functional groups.
Optimization, in this context, can have at least two meanings. If the result of the
optimized network is to accelerate the flow of information, then the optimized
sub-network should have a higher frequency in biological networks. If
acceleration of information flow is a secondary result of the optimization, and the
primary result is to control the expression of pathways connected to the motif,
then the sub-network should have a lower frequency in biological networks. I
expected the second meaning of optimization to include biomolecular signaling
networks associated with control. Although the design of this study was heavily
influenced by these definitions, they are not exhaustive and need further
investigation prior to being considered theory.
This study was limited to the optimization associated with pathway control
seen in the Apoptosis in Lung Cancer network and the Autism network. This is
because these two networks had the highest confidence, while being significantly
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diverse and of large enough size. After normalization by use of the semantic
analysis of the PSI-MI tags, the Apoptosis network had 3400 nodes representing
proteins, genes, ligands and small molecules. This network also had 5857 edges.
Compared to the original network of 5724 nodes and 13810 edges, there was a
reduction of 41% by node and a 58% reduction by edge from the semantic
optimization. This optimization likely influenced the occurrence of the subnetworks by removing false positives. In each of the four node networks, tested
in the CA simulation of the Bcl2 family proteins, the occurrence in the apoptosis
network was lower than the null hypothesis (mean occurrence in simulated
random networks), the opposite occurred in the Autism network. The three 4node sub-networks are displayed in figures 18-21 (reproduced below).
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Figure 24 – 4-Node, 4-Edge
Non-Symmetrical Non-Linear
Motif

Figure 25 – 4-Node, 4-Edge
Symmetrical Non-Linear Bi-Fan
Motif

Figure 26 – 4-Node, 4-Edge Biparallel Motif

Figure 27 – 6-Node, 9-Edge Tri-parallel Motif

Figure 28 – 5-Node, 6-Edge Tri-parallel Motif

The motif in Figure 18 occurred at a ratio of 0.10 (ratio = (observed in
network)/(mean occurrence in random networks)) in the Apoptosis network,
versus 1.62 in the Autism network. This pattern continues through the motif in
Figure 20 where the apoptosis network had a ratio of 0.67, vs. 2.07 in the Autism
network. It also occurs in the motif in Figure 19 where the apoptosis network had
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a ratio of 0.04, compared to 5.41 in the Autism network. Additionally this
continued in the 6-node, 9-edge motif in Figure 21. The motif in Figure 22 could
not be compared, because it was not significant in the apoptosis network, but the
pattern remained in the Autism one.
The ratio of the motifs found in apoptosis (Table 7), were consistently low
in apoptosis and consistently high in the autism network. The consistency of
these results suggests there are fundamental differences in the apoptosis
signaling and autism networks. Apoptosis has been studied in detail for decades,
producing a wealth of interaction data available in the databases used in this
study. Autism has only recently received attention and little of the pathogenicity
of autism is understood. The apoptosis network needed to be normalized to
remove the noise of repeat or irrelevant data that was produced by a basic
search that yielded more proteins than could occur naturally. Autism required
multiple search attempts revealing a single data-source of uncurated metadata. A
possible reason for this inconsistency is the apoptosis signaling network is
focused on one group of functions, those of cell death through apoptosis, and it is
well understood and heavily studied.

The autism network is likely a mix of

functional groups and is still very incomplete. In apoptosis, these motifs do
represent regions of functional control and therefore occur at a lower ratio when
compared to random networks. In Autism these motifs are over represented
because Autism is associated with a mix of functional groups and the network is
incomplete. Additionally, in autism these motifs are occurring at a higher ratio
because their role in controlling signaling and pathway selection/function
increases the likelihood they are observed during the onset of autism.
Based on this result, the ratio of motifs could be used to identify whether a
larger network represents more than one functional group, possibly as a measure
of biomolecular network completeness. Although this is not evidence the
hypothesis holds true, this study suggests the ratio of these motifs area a
reporter for the presence or absence of functional groups in larger biomolecular
networks.
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Future work
In order to understand the entire role of each of these motifs that hint at
function, a study of the expression of their associated genes and proteins needs
to be done. This would require the creation of a software based tool that will
extract expression data from a data-source, calculate the average across all
related disease types and stages, and then compare the ratio of occurrence of
the motif with the expression of each gene and protein represented in the
network. Cytoscape’s NetMatch would be an excellent tool because it has the
ability to report the identity of each motif, even with over-represented interactions
(where more than one edge is present between two nodes). The result of this
study would be a list of network motifs and genes/proteins that would increase
the likelihood for the network to be complete, and whether it includes few or
many functional groups. This would be a significant expansion of the use of
network motifs in studying biomolecular networks and their control of cell function
and disease.
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SUMMARY: The microbial protein interaction database (MPIDB) aims to collect
and provide all known physical microbial interactions. Currently, 22,530
experimentally determined interactions among proteins of 191 bacterial
species/strains can be browsed and downloaded. These microbial interactions
have been manually curated from the literature or imported from other databases
(IntAct, DIP, BIND, MINT) and are linked to 24,060 experimental evidences
(PubMed ID, PSI-MI methods). In contrast to these databases, interactions in
MPIDB are further supported by 8150 additional evidences based on interaction
conservation, co-purification and 3D domain contacts (iPfam, 3did).
AVAILABILITY: http://www.jcvi.org/mpidb/
Gregg, J. P., L. Lit, et al. (2008). "Gene expression changes in children with autism."
Genomics 91(1): 22-9.
Hoffmann, R. and A. Valencia (2004). "A gene network for navigating the literature."
Nat Genet 36(7): 664.
Hu, V. W., B. C. Frank, et al. (2006). "Gene expression profiling of lymphoblastoid cell
lines from monozygotic twins discordant in severity of autism reveals differential
regulation of neurologically relevant genes." BMC Genomics 7: 118.
Insel, T. R. and T. Lehner (2007). "A new era in psychiatric genetics?" Biol Psychiatry
61(9): 1017-8.
Jourdan, M., T. Reme, et al. (2009). "Gene expression of anti- and pro-apoptotic proteins
in malignant and normal plasma cells." Br J Haematol 145(1): 45-58.
The survival of malignant plasma cells is a key event in disease occurrence,
progression and chemoresistance. Using DNA-microarrays, we analysed the
expression of genes coding for 58 proteins linked with extrinsic and intrinsic
apoptotic pathways, caspases and inhibitor of apoptosis proteins. We considered
six memory B cells (MBC), seven plasmablasts (PPC), seven bone marrow
plasma cells (BMPC) and purified myeloma cells (MMC) from 92 newlydiagnosed patients. Forty out of the 58 probe sets enabled the separation of MBC,
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PPC and BMPC in three homogeneous clusters, characterized by an elevated
expression of TNFRSF10A, TNFRSF10B, BCL2A1, CASP8, CASP9 and
PMAIP1 genes for MBC, of FAS, FADD, AIFM1, BIRC5, CASP CASP2,
CASP3 and CASP6 for PPC and of BCL2, MCL1, BID, BIRC3 and XIAP for
BMPC. Thus, B cell differentiation was associated with change of expression of
pro-apoptotic and anti-apoptotic genes. Regarding MMC, the major finding was
TRAIL upregulation that might be counteracted by a high osteoprotegerin
production by BM stromal cells and a decreased expression of FAS, APAF1 and
BNIP3 compared to normal BMPC. Out of the 40 genes, CASP2 and BIRC5
expression in MMC had adverse prognosis in two independent series of
previously-untreated patients.
Kaser, O., Lamire, D. (2007). Tag-Cloud Drawing: Algorithms for Cloud Visualization.
Tagging and Metadata for Social Information Organization (WWW 2007).
Kerrien, S., Y. Alam-Faruque, et al. (2007). "IntAct--open source resource for molecular
interaction data." Nucleic Acids Res 35(Database issue): D561-5.
IntAct is an open source database and software suite for modeling, storing and
analyzing molecular interaction data. The data available in the database originates
entirely from published literature and is manually annotated by expert biologists
to a high level of detail, including experimental methods, conditions and
interacting domains. The database features over 126,000 binary interactions
extracted from over 2100 scientific publications and makes extensive use of
controlled vocabularies. The web site provides tools allowing users to search,
visualize and download data from the repository. IntAct supports and encourages
local installations as well as direct data submission and curation collaborations.
IntAct source code and data are freely available from http://www.ebi.ac.uk/intact.
Kier, L. B. (2008). "A review of recent studies relating ligand diffusion, general
anesthesia, and sleep." AANA J 76(2): 109-12.
This review article presents 3 theories related to ligand diffusion, general
anesthesia and sleep. The first theory describes the diffusion of molecules across a
protein surface to a receptor. It is based on the effect of the amino acid side chains
on the protein surface on the structure of bulk water nearby. This influence creates
pathways, called chreodes, through the water near the protein surface, permitting
a rapid diffusion of molecules to the receptors. A second theory involving the role
of chreodes presents a mechanism of action of nonspecific anesthetic agents.
These agents interrupt the diffusion of neurotransmitter molecules to their
receptors, bringing on the anesthetic effects. Finally, building on the similarities
of anesthesia and sleep, a theory is presented proposing that an external agent
influences sleep in a way similar to that of the nonspecific anesthetic molecules.
This external agent is proposed to be elemental nitrogen. Several observations are
presented to support this mechanism.
Kier, L. B., D. Bonchev, et al. (2005). "Modeling biochemical networks: a cellularautomata approach." Chem Biodivers 2(2): 233-43.
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The potential of the cellular-automata (CA) method for modeling biological
networks is demonstrated for the mitogen-activated protein kinase (MAPK)
signaling cascade. The models derived reproduced the high signal amplification
through the cascade and the deviation of the cascade enzymes from the MichaelisMenten kinetics, evidencing cooperativity effects. The patterns of pathway
change upon varying substrate concentrations and enzyme efficiencies were
identified and used to show the ways for controlling pathway processes. Guidance
in the selection of enzyme inhibition targets with minimum side effects is one
outcome of the study.
Kier, L. B., P. G. Seybold, et al. (2010). Cellular Automata Modeling of Chemical
Systems, Springer.
Kuznetsov, V., S. Thomas, et al. (2008). "Data-driven Networking Reveals 5-Genes
Signature for Early Detection of Lung Cancer." 2008 International Conference on
BioMedical Engineering and Informatics 1: 413-417.
Medina, P. P., J. Carretero, et al. (2005). "Transcriptional targets of the chromatinremodelling factor SMARCA4/BRG1 in lung cancer cells." Hum Mol Genet 14(7): 97382.
BRG1, also called SMARCA4, is the catalytic subunit of the SWI/SNF
chromatin-remodelling complex and influences transcriptional regulation by
disrupting histone-DNA contacts in an ATP-dependent manner. BRG1 and other
members of the SWI/SNF complex become inactivated in tumours, implying a
role in cancer development. To understand the contribution of BRG1 to lung
tumourigenesis, we restored BRG1 in H1299 lung cancer cells and used cDNA
microarray analysis to identify changes in gene expression. Forty-three transcripts
became activated, whereas two were repressed. Chromatin immunoprecipitation
of resulting candidate genes revealed that the CYP3A4 and ZNF185 promoters
recruited BRG1 and that recruitment to the CYP3A4 promoter was specific to this
gene and did not involve the CYP3A5 or CYP3A7 family members. Moreover,
specifically BRG1 but not its homologue BRM was recruited to the CYP3A4 and
ZNF185 promoters. To explore their potential relevance in lung tumours, levels of
CYP3A4 and ZNF185 transcripts were evaluated in seven additional lung cancer
cell lines. CYP3A4 was undetectable in any of the lung cancer cells tested, and
only the CYP3A5 family member was present in the A549 and Calu-3 cells. In
contrast, the amount of ZNF185 transcript clearly varied among lung cancer cell
lines and severely reduced levels were observed in BRG1-deficient cells, except
those of A427. We extended these observations to 27 lung primary tumours using
real-time RT-PCR (TaqMan) and observed that four (15%) and 14 (52%) of them
had BRG1 and ZNF185 downregulation, respectively, when compared with
normal lung. No significant correlation between reduced levels of BRG1 and
ZNF185 was observed, indicating that additional mechanisms to BRG1
inactivation may contribute to the loss of ZNF185 expression in lung tumours. In
conclusion, our results provide evidence that transcriptional activation of ZNF185
and CYP3A4 is mediated by direct association of BRG1 with their promoters and
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also indicate that a decreased level of ZNF185 is a common feature of lung
tumours and may be of biological relevance in lung carcinogenesis.
Milo, R., S. Shen-Orr, et al. (2002). "Network motifs: simple building blocks of complex
networks." Science 298(5594): 824-7.
Complex networks are studied across many fields of science. To uncover their
structural design principles, we defined "network motifs," patterns of
interconnections occurring in complex networks at numbers that are significantly
higher than those in randomized networks. We found such motifs in networks
from biochemistry, neurobiology, ecology, and engineering. The motifs shared by
ecological food webs were distinct from the motifs shared by the genetic networks
of Escherichia coli and Saccharomyces cerevisiae or from those found in the
World Wide Web. Similar motifs were found in networks that perform
information processing, even though they describe elements as different as
biomolecules within a cell and synaptic connections between neurons in
Caenorhabditis elegans. Motifs may thus define universal classes of networks.
This approach may uncover the basic building blocks of most networks.
Montecchi-Palazzi, L., S. Kerrien, et al. (2009). "The PSI semantic validator: a
framework to check MIAPE compliance of proteomics data." Proteomics 9(22): 5112-9.
The Human Proteome Organization's Proteomics Standards Initiative (PSI)
promotes the development of exchange standards to improve data integration and
interoperability. PSI specifies the suitable level of detail required when reporting
a proteomics experiment (via the Minimum Information About a Proteomics
Experiment), and provides extensible markup language (XML) exchange formats
and dedicated controlled vocabularies (CVs) that must be combined to generate a
standard compliant document. The framework presented here tackles the issue of
checking that experimental data reported using a specific format, CVs and public
bio-ontologies (e.g. Gene Ontology, NCBI taxonomy) are compliant with the
Minimum Information About a Proteomics Experiment recommendations. The
semantic validator not only checks the XML syntax but it also enforces rules
regarding the use of an ontology class or CV terms by checking that the terms
exist in the resource and that they are used in the correct location of a document.
Moreover, this framework is extremely fast, even on sizable data files, and
flexible, as it can be adapted to any standard by customizing the parameters it
requires: an XML Schema Definition, one or more CVs or ontologies, and a
mapping file describing in a formal way how the semantic resources and the
format are interrelated. As such, the validator provides a general solution to the
common problem in data exchange: how to validate the correct usage of a data
standard beyond simple XML Schema Definition validation. The framework
source code and its various applications can be found at
http://psidev.info/validator.
Nelson, R. T., S. Avraham, et al. "Applications and methods utilizing the Simple
Semantic Web Architecture and Protocol (SSWAP) for bioinformatics resource discovery
and disparate data and service integration." BioData Min 3(1): 3.
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ABSTRACT: BACKGROUND: Scientific data integration and computational
service discovery are challenges for the bioinformatic community. This process is
made more difficult by the separate and independent construction of biological
databases, which makes the exchange of data between information resources
difficult and labor intensive. A recently described semantic web protocol, the
Simple Semantic Web Architecture and Protocol (SSWAP; pronounced "swap")
offers the ability to describe data and services in a semantically meaningful way.
We report how three major information resources (Gramene, SoyBase and the
Legume Information System [LIS]) used SSWAP to semantically describe
selected data and web services. METHODS: We selected high-priority
Quantitative Trait Locus (QTL), genomic mapping, trait, phenotypic, and
sequence data and associated services such as BLAST for publication, data
retrieval, and service invocation via semantic web services. Data and services
were mapped to concepts and categories as implemented in legacy and de novo
community ontologies. We used SSWAP to express these offerings in OWL Web
Ontology Language (OWL), Resource Description Framework (RDF) and
eXtensible Markup Language (XML) documents, which are appropriate for their
semantic discovery and retrieval. We implemented SSWAP services to respond to
web queries and return data. These services are registered with the SSWAP
Discovery Server and are available for semantic discovery at http://sswap.info.
RESULTS: A total of ten services delivering QTL information from Gramene
were created. From SoyBase, we created six services delivering information about
soybean QTLs, and seven services delivering genetic locus information. For LIS
we constructed three services, two of which allow the retrieval of DNA and RNA
FASTA sequences with the third service providing nucleic acid sequence
comparison capability (BLAST). CONCLUSIONS: The need for semantic
integration technologies has preceded available solutions. We report the
feasibility of mapping high priority data from local, independent, idiosyncratic
data schemas to common shared concepts as implemented in web-accessible
ontologies. These mappings are then amenable for use in semantic web services.
Our implementation of approximately two dozen services means that biological
data at three large information resources (Gramene, SoyBase, and LIS) is
available for programmatic access, semantic searching, and enhanced interaction
between the separate missions of these resources.
Neumann, J. V. and A. W. Burks (1966). Theory of Self-Reproducing Automata. Urbana
and London, University of Illinois Press.
Nikitin, A., S. Egorov, et al. (2003). "Pathway studio--the analysis and navigation of
molecular networks." Bioinformatics 19(16): 2155-7.
SUMMARY: PathwayAssist is a software application developed for navigation
and analysis of biological pathways, gene regulation networks and protein
interaction maps. It comes with the built-in natural language processing module
MedScan and the comprehensive database describing more than 100 000 events
of regulation, interaction and modification between proteins, cell processes and
small molecules. AVAILABILITY: PathwayAssist is available for commercial
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licensing from Ariadne Genomics, Inc. The light version with limited
functionality will be available for free for academic users at
www.ariadnegenomics.com/downloads/.
Nishimura, Y., C. L. Martin, et al. (2007). "Genome-wide expression profiling of
lymphoblastoid cell lines distinguishes different forms of autism and reveals shared
pathways." Hum Mol Genet 16(14): 1682-98.
Overington, J. (2009). "ChEMBL. An interview with John Overington, team leader,
chemogenomics at the European Bioinformatics Institute Outstation of the European
Molecular Biology Laboratory (EMBL-EBI). Interview by Wendy A. Warr." J Comput
Aided Mol Des 23(4): 195-8.
Purcell, A. E., O. H. Jeon, et al. (2001). "Postmortem brain abnormalities of the
glutamate neurotransmitter system in autism." Neurology 57(9): 1618-28.
Razick, S., G. Magklaras, et al. (2008). "iRefIndex: a consolidated protein interaction
database with provenance." BMC Bioinformatics 9: 405.
BACKGROUND: Interaction data for a given protein may be spread across
multiple databases. We set out to create a unifying index that would facilitate
searching for these data and that would group together redundant interaction data
while recording the methods used to perform this grouping. RESULTS: We
present a method to generate a key for a protein interaction record and a key for
each participant protein. These keys may be generated by anyone using only the
primary sequence of the proteins, their taxonomy identifiers and the Secure Hash
Algorithm. Two interaction records will have identical keys if they refer to the
same set of identical protein sequences and taxonomy identifiers. We define
records with identical keys as a redundant group. Our method required that we
map protein database references found in interaction records to current protein
sequence records. Operations performed during this mapping are described by a
mapping score that may provide valuable feedback to source interaction databases
on problematic references that are malformed, deprecated, ambiguous or unfound.
Keys for protein participants allow for retrieval of interaction information
independent of the protein references used in the original records.
CONCLUSION: We have applied our method to protein interaction records from
BIND, BioGrid, DIP, HPRD, IntAct, MINT, MPact, MPPI and OPHID. The
resulting interaction reference index is provided in PSI-MITAB 2.5 format at
http://irefindex.uio.no. This index may form the basis of alternative redundant
groupings based on gene identifiers or near sequence identity groupings.
Reisman, D. N., J. Sciarrotta, et al. (2003). "Loss of BRG1/BRM in human lung cancer
cell lines and primary lung cancers: correlation with poor prognosis." Cancer Res 63(3):
560-6.
A role for the SWI/SNF complex in tumorigenesis based on its requirement for
retinoblastoma induced growth arrest and p53-mediated transcription and the
appearance of tumors in SWI/SNF-deficient mice. In addition, Western blot data
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have shown that the SWI/SNF ATPase subunits cell, BRG1 and BRM
(BRG1/BRM), are lost in approximately 30% of human non-small lung cancer
cell lines. To determine whether loss of expression of these proteins occurs in
primary tumors, we examined their expression in 41 primary lung
adenocarcinomas and 19 primary lung squamous carcinomas by
immunohistochemistry. These analyses showed that 10% of tumors show a
concomitant loss of BRG1 and BRM expression. Moreover, patients with
BRG1/BRM-negative carcinomas, independent of stage, have a statistically
significant decrease in survival compared with patients with BRG1/BRM. This
report provides supportive evidence that BRG1 and BRM act as tumor suppressor
proteins and implicates a role for their loss in the development of non-small cell
lung cancers.
Renouf, D. J., R. Wood-Baker, et al. (2009). "BCL-2 expression is prognostic for
improved survival in non-small cell lung cancer." J Thorac Oncol 4(4): 486-91.
OBJECTIVE: We used a large patient population to identify
immunohistochemical biomarkers to enable improved prognostication in patients
with non-small cell lung carcinoma (NSCLC). METHODS: A tissue microarray
was constructed using duplicate 0.6 mm cores of formalin-fixed paraffinembedded tissue blocks from 609 patients with NSCLC. Immunohistochemical
was used to detect 11 biomarkers including epidermal growth factor receptor,
Her2, Her3, p53, p63, bcl-1, bcl-2, Thyroid transcription factor, carcinoembryonic
antigen, chromogranin, and synaptophysin. A clinical database was generated
prospectively at the time of tissue collection. Survival outcomes were obtained
from a Provincial Cancer Registry database. Univariate and multivariate analyses
were performed to look for a relationship between biomarker expression, smoking
history, and survival. RESULTS: Survival data for 535 cases were available. As
of June 2005, 429 patients (80%) had died; of these 286 (54%) died of lung
cancer, 117 (22%) died of other known causes, and for 26 (5%) the cause of death
was not available. Univariate analysis revealed that bcl-2 (p = 0.007) was the only
biomarker prognostic for improved overall survival (OS). bcl-2 (p = 0.021) and
p63 (p = 0.025) were both found to be prognostic for improved disease-specific
survival (DSS). Multivariate analysis (using age and biomarker expression)
revealed that bcl-2 expression is prognostic for improved OS (p = 0.005) and DSS
(p = 0.021). CONCLUSIONS: Our results suggest that bcl-2 expression is
prognostic for improved OS and DSS in NSCLC. Testing for bcl-2 expression in a
prospective study will help to determine its clinical relevance in prognostication.
Rhodes, D. R., S. Kalyana-Sundaram, et al. (2007). "Oncomine 3.0: genes, pathways, and
networks in a collection of 18,000 cancer gene expression profiles." Neoplasia 9(2): 16680.
DNA microarrays have been widely applied to cancer transcriptome analysis;
however, the majority of such data are not easily accessible or comparable.
Furthermore, several important analytic approaches have been applied to
microarray analysis; however, their application is often limited. To overcome
these limitations, we have developed Oncomine, a bioinformatics initiative aimed
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at collecting, standardizing, analyzing, and delivering cancer transcriptome data to
the biomedical research community. Our analysis has identified the genes,
pathways, and networks deregulated across 18,000 cancer gene expression
microarrays, spanning the majority of cancer types and subtypes. Here, we
provide an update on the initiative, describe the database and analysis modules,
and highlight several notable observations. Results from this comprehensive
analysis are available at http://www.oncomine.org.
Rives, A. W. and T. Galitski (2003). "Modular organization of cellular networks." Proc
Natl Acad Sci U S A 100(3): 1128-33.
Sasaki, H., S. Moriyama, et al. (2004). "Histone deacetylase 1 mRNA expression in lung
cancer." Lung Cancer 46(2): 171-8.
Histone deacetylases (HDACs) play a crucial role in tumorigenesis, however, the
expression status of HDACs in lung cancer tissues has not been reported. We
have investigated that HIDAC 1 mRNA levels and other clinico-pathological
data, including MTA 1 mRNA expression in lung cancer. The study included 102
lung cancer cases. The HDAC1 mRNA levels were quantified by real time
reverse transcription-polymerase chain reaction (RT-PCR) using LightCycler
(Roche Molecular Biochemicals, Mannheim, Germany). The HDAC1/GAPDH
mRNA levels were not significantly different in tumor tissues from lung cancer
(30.654 +/- 33.047) and adjacent non-malignant lung tissues (18.953 +/- 56.176 ,
P = 0.1827). No significant difference in HDAC1/GAPDH mRNA levels was
found among age, gender, and lymph node metastasis. The HDAC1/GAPDH
mRNA levels were significantly higher in stage III or IV lung cancer (50.929 +/120.433) than in stage I lung cancer (11.430 +/- 25.611, P = 0.0472).
HDAC1/GAPDH mRNA levels were significantly higher in T3 or T4 lung
carcinoma (54.326 +/- 127.018) than in T1 or T2 lung cancers (14.790 +/- 48.670,
P = 0.1601). HDAC1/GAPDH mRNA levels were correlated with
MTA1/GAPDH mRNA levels (y = 0.0106x + 2.5827 , P = 0.0352 ).
HDAC1/GAPDH mRNA levels were also correlated with HDAC1 protein (P =
0.0484) expression by immunohistochemistry. Using the LightCycler RT-PCR
assay, the HDAC1 gene expression might correlate with progression of lung
cancers. However, further studies are needed to confirm the impact of HDAC1 for
the molecular target of the lung cancer.
Sayers, E. W., T. Barrett, et al. "Database resources of the National Center for
Biotechnology Information." Nucleic Acids Res 38(Database issue): D5-16.
In addition to maintaining the GenBank nucleic acid sequence database, the
National Center for Biotechnology Information (NCBI) provides analysis and
retrieval resources for the data in GenBank and other biological data made
available through the NCBI web site. NCBI resources include Entrez, the Entrez
Programming Utilities, MyNCBI, PubMed, PubMed Central, Entrez Gene, the
NCBI Taxonomy Browser, BLAST, BLAST Link (BLink), Electronic PCR,
OrfFinder, Spidey, Splign, Reference Sequence, UniGene, HomoloGene,
ProtEST, dbMHC, dbSNP, Cancer Chromosomes, Entrez Genomes and related
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tools, the Map Viewer, Model Maker, Evidence Viewer, Trace Archive, Sequence
Read Archive, Retroviral Genotyping Tools, HIV-1/Human Protein Interaction
Database, Gene Expression Omnibus, Entrez Probe, GENSAT, Online Mendelian
Inheritance in Man, Online Mendelian Inheritance in Animals, the Molecular
Modeling Database, the Conserved Domain Database, the Conserved Domain
Architecture Retrieval Tool, Biosystems, Peptidome, Protein Clusters and the
PubChem suite of small molecule databases. Augmenting many of the web
applications are custom implementations of the BLAST program optimized to
search specialized data sets. All these resources can be accessed through the
NCBI home page at www.ncbi.nlm.nih.gov.
Scardoni, G., M. Petterlini, et al. (2009). "Analyzing biological network parameters with
CentiScaPe." Bioinformatics 25(21): 2857-9.
SUMMARY: The increasing availability of large network datasets along with the
progresses in experimental high-throughput technologies have prompted the need
for tools allowing easy integration of experimental data with data derived form
network computational analysis. In order to enrich experimental data with
network topological parameters, we have developed the Cytoscape plug-in
CentiScaPe. The plug-in computes several network centrality parameters and
allows the user to analyze existing relationships between experimental data
provided by the users and node centrality values computed by the plug-in.
CentiScaPe allows identifying network nodes that are relevant from both
experimental and topological viewpoints. CentiScaPe also provides a Boolean
logic-based tool that allows easy characterization of nodes whose topological
relevance depends on more than one centrality. Finally, different graphic outputs
and the included description of biological significance for each computed
centrality facilitate the analysis by the end users not expert in graph theory, thus
allowing easy node categorization and experimental prioritization.
AVAILABILITY: CentiScaPe can be downloaded via the Cytoscape web site:
http://chianti.ucsd.edu/cyto_web/plugins/index.php. Tutorial, centrality
descriptions and example data are available at: http://profs.sci.univr.it/
approximately scardoni/centiscape/centiscapepage.php CONTACT:
giovanni.scardoni@gmail.com SUPPLEMENTARY INFORMATION:
Supplementary data are available at Bioinformatics online.
Sherman, B. T., W. Huang da, et al. (2007). "DAVID Knowledgebase: a gene-centered
database integrating heterogeneous gene annotation resources to facilitate highthroughput gene functional analysis." BMC Bioinformatics 8: 426.
BACKGROUND: Due to the complex and distributed nature of biological
research, our current biological knowledge is spread over many redundant
annotation databases maintained by many independent groups. Analysts usually
need to visit many of these bioinformatics databases in order to integrate
comprehensive annotation information for their genes, which becomes one of the
bottlenecks, particularly for the analytic task associated with a large gene list.
Thus, a highly centralized and ready-to-use gene-annotation knowledgebase is in
demand for high throughput gene functional analysis. DESCRIPTION: The
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DAVID Knowledgebase is built around the DAVID Gene Concept, a singlelinkage method to agglomerate tens of millions of gene/protein identifiers from a
variety of public genomic resources into DAVID gene clusters. The grouping of
such identifiers improves the cross-reference capability, particularly across NCBI
and UniProt systems, enabling more than 40 publicly available functional
annotation sources to be comprehensively integrated and centralized by the
DAVID gene clusters. The simple, pair-wise, text format files which make up the
DAVID Knowledgebase are freely downloadable for various data analysis uses.
In addition, a well organized web interface allows users to query different types of
heterogeneous annotations in a high-throughput manner. CONCLUSION: The
DAVID Knowledgebase is designed to facilitate high throughput gene functional
analysis. For a given gene list, it not only provides the quick accessibility to a
wide range of heterogeneous annotation data in a centralized location, but also
enriches the level of biological information for an individual gene. Moreover, the
entire DAVID Knowledgebase is freely downloadable or searchable at
http://david.abcc.ncifcrf.gov/knowledgebase/.
Sprinzak, E., S. J. Cokus, et al. (2009). "Detecting coordinated regulation of multi-protein
complexes using logic analysis of gene expression." BMC Syst Biol 3: 115.
BACKGROUND: Many of the functional units in cells are multi-protein
complexes such as RNA polymerase, the ribosome, and the proteasome. For such
units to work together, one might expect a high level of regulation to enable coappearance or repression of sets of complexes at the required time. However, this
type of coordinated regulation between whole complexes is difficult to detect by
existing methods for analyzing mRNA co-expression. We propose a new
methodology that is able to detect such higher order relationships. RESULTS: We
detect coordinated regulation of multiple protein complexes using logic analysis
of gene expression data. Specifically, we identify gene triplets composed of genes
whose expression profiles are found to be related by various types of logic
functions. In order to focus on complexes, we associate the members of a gene
triplet with the distinct protein complexes to which they belong. In this way, we
identify complexes related by specific kinds of regulatory relationships. For
example, we may find that the transcription of complex C is increased only if the
transcription of both complex A AND complex B is repressed. We identify
hundreds of examples of coordinated regulation among complexes under various
stress conditions. Many of these examples involve the ribosome. Some of our
examples have been previously identified in the literature, while others are novel.
One notable example is the relationship between the transcription of the ribosome,
RNA polymerase and mannosyltransferase II, which is involved in N-linked
glycan processing in the Golgi. CONCLUSIONS: The analysis proposed here
focuses on relationships among triplets of genes that are not evident when genes
are examined in a pairwise fashion as in typical clustering methods. By grouping
gene triplets, we are able to decipher coordinated regulation among sets of three
complexes. Moreover, using all triplets that involve coordinated regulation with
the ribosome, we derive a large network involving this essential cellular complex.
In this network we find that all multi-protein complexes that belong to the same
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functional class are regulated in the same direction as a group (either induced or
repressed).
Stark, C., B. J. Breitkreutz, et al. "The BioGRID Interaction Database: 2011 update."
Nucleic Acids Res.
The Biological General Repository for Interaction Datasets (BioGRID) is a public
database that archives and disseminates genetic and protein interaction data from
model organisms and humans (http://www.thebiogrid.org). BioGRID currently
holds 347 966 interactions (170 162 genetic, 177 804 protein) curated from both
high-throughput data sets and individual focused studies, as derived from over 23
000 publications in the primary literature. Complete coverage of the entire
literature is maintained for budding yeast (Saccharomyces cerevisiae), fission
yeast (Schizosaccharomyces pombe) and thale cress (Arabidopsis thaliana), and
efforts to expand curation across multiple metazoan species are underway. The
BioGRID houses 48 831 human protein interactions that have been curated from
10 247 publications. Current curation drives are focused on particular areas of
biology to enable insights into conserved networks and pathways that are relevant
to human health. The BioGRID 3.0 web interface contains new search and display
features that enable rapid queries across multiple data types and sources. An
automated Interaction Management System (IMS) is used to prioritize, coordinate
and track curation across international sites and projects. BioGRID provides
interaction data to several model organism databases, resources such as EntrezGene and other interaction meta-databases. The entire BioGRID 3.0 data
collection may be downloaded in multiple file formats, including PSI MI XML.
Source code for BioGRID 3.0 is freely available without any restrictions.
Stein, L. D. (2004). "Human genome: end of the beginning." Nature 431(7011): 915-6.
Strogatz, S. H. (2001). "Exploring complex networks." Nature 410(6825): 268-76.
Su, L. J., C. W. Chang, et al. (2007). "Selection of DDX5 as a novel internal control for
Q-RT-PCR from microarray data using a block bootstrap re-sampling scheme." BMC
Genomics 8: 140.
Thomas, P. D., M. J. Campbell, et al. (2003). "PANTHER: a library of protein families
and subfamilies indexed by function." Genome Res 13(9): 2129-41.
In the genomic era, one of the fundamental goals is to characterize the function of
proteins on a large scale. We describe a method, PANTHER, for relating protein
sequence relationships to function relationships in a robust and accurate way.
PANTHER is composed of two main components: the PANTHER library
(PANTHER/LIB) and the PANTHER index (PANTHER/X). PANTHER/LIB is a
collection of "books," each representing a protein family as a multiple sequence
alignment, a Hidden Markov Model (HMM), and a family tree. Functional
divergence within the family is represented by dividing the tree into subtrees
based on shared function, and by subtree HMMs. PANTHER/X is an abbreviated
ontology for summarizing and navigating molecular functions and biological
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processes associated with the families and subfamilies. We apply PANTHER to
three areas of active research. First, we report the size and sequence diversity of
the families and subfamilies, characterizing the relationship between sequence
divergence and functional divergence across a wide range of protein families.
Second, we use the PANTHER/X ontology to give a high-level representation of
gene function across the human and mouse genomes. Third, we use the family
HMMs to rank missense single nucleotide polymorphisms (SNPs), on a databasewide scale, according to their likelihood of affecting protein function.
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The behaviors of autism overlap with a diverse array of other neurological
disorders, suggesting common molecular mechanisms. We conducted a large
comparative analysis of the network of genes linked to autism with those of 432
other neurological diseases to circumscribe a multi-disorder subcomponent of
autism. We leveraged the biological process and interaction properties of these
multi-disorder autism genes to overcome the across-the-board multiple hypothesis
corrections that a purely data-driven approach requires. Using prior knowledge of
biological process, we identified 154 genes not previously linked to autism of
which 42% were significantly differentially expressed in autistic individuals.
Then, using prior knowledge from interaction networks of disorders related to
autism, we uncovered 334 new genes that interact with published autism genes, of
which 87% were significantly differentially regulated in autistic individuals. Our
analysis provided a novel picture of autism from the perspective of related
neurological disorders and suggested a model by which prior knowledge of
interaction networks can inform and focus genome-scale studies of complex
neurological disorders.
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SUMMARY: Motifs are small connected subnetworks that a network displays in
significantly higher frequencies than would be expected for a random network.
They have recently gathered much attention as a concept to uncover structural
design principles of complex biological networks. FANMOD is a tool for fast
network motif detection; it relies on recently developed algorithms to improve the
efficiency of network motif detection by some orders of magnitude over existing
tools. This facilitates the detection of larger motifs in bigger networks than
previously possible. Additional benefits of FANMOD are the ability to analyze
colored networks, a graphical user interface and the ability to export results to a
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The antiapoptotic oncoprotein Bcl-2 is now a recognized phototarget of
photodynamic therapy (PDT) with the phthalocyanine Pc 4 and with other
mitochondrion-targeting photosensitizers. Photodamage, observed on Western
blots as the loss of the native 26-kDa Bcl-2 protein, is PDT dose dependent and
occurs in multiple cell lines, in the cold, and immediately upon photoirradiation.
In our initial study, no photochemical damage was observed to Bcl-xL, in spite of
its similarity in size, sequence, location and function to Bcl-2. The original study
used a commercial anti-Bcl-xS/L antibody. We have revisited this issue by
examining Western blots developed using one of three epitope-specific anti-BclxL antibodies from commercial sources, a polyclonal antibody generated to the
entire protein, as well as the antibody used previously. All five Bcl-xL antibodies
recognized bacterially expressed Bcl-xL, but not Bcl-2, whereas an anti-Bcl-2
antibody recognized Bcl-2 and not Bcl-xL. All five Bcl-xL antibodies recognized
at least one protein migrating at approximately 30 kDa; two of the antibodies
recognized an additional band, migrating at approximately 33 or approximately
24 kDa. We now observe Pc 4-PDT-induced photodamage to all Bcl-xL-related
proteins, except the 33-kDa species, in several human cancer cell lines. The
results indicate that, in addition to the expected quantitative differences that may
reflect exposure of individual epitopes, the antibodies also detect proteins of
different apparent molecular weights that may be distinct isoforms or posttranslationally modified forms of Bcl-xL. No evidence for PDT-induced
phosphorylation or degradation was observed. Bcl-xL localized to mitochondria
was considerably more sensitive to photodamage than was Bcl-xL in the cytosol,
indicating that as previously found for Bcl-2, Bcl-xL must be membrane localized
to be photosensitive.
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Gene expression profiling provides unprecedented opportunities to study patterns
of gene expression regulation, for example, in diseases or developmental
processes. Bioinformatics analysis plays an important part of processing the
information embedded in large-scale expression profiling studies and for laying
the foundation for biological interpretation. Over the past years, numerous tools
have emerged for microarray data analysis. One of the most popular platforms is
Bioconductor, an open source and open development software project for the
analysis and comprehension of genomic data, based on the R programming
language. In this chapter, we use Bioconductor analysis packages on a heart
development dataset to demonstrate the workflow of microarray data analysis
from annotation, normalization, expression index calculation, and diagnostic plots
to pathway analysis, leading to a meaningful visualization and interpretation of
the data.
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